BioNote

BioNote Financing Cash Flow

Net Financing Cash Flow of BioNote (377740.KS) as of Oct 9, 2026.

Financing Cash Flow

-KRW

Last updated:

Net Financing Cash Flow of BioNote is 2026 - KRW. Net Financing Cash Flow of BioNote was 2025 -24.66 B KRW. It decreases by % lower compared to the previous year.

The BioNote Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2019
26.75 B KRW
Jan 1, 2020
-11.66 B KRW
Jan 1, 2021
-50.60 B KRW
Jan 1, 2022
22.96 B KRW
Jan 1, 2023
-49.90 B KRW
Jan 1, 2024
-24.66 B KRW
The BioNote Financing Cash Flow history
YEARFinancing Cash FlowYoY
-24.66 BKRW-50.58%
-49.90 BKRW-317.39%
22.96 BKRW-145.37%
-50.60 BKRW+333.77%
-11.66 BKRW-143.60%
26.75 BKRW—
Access this data via the Eulerpool API
Get Free API Key

BioNote Stock analysis

What does BioNote do? BioNote is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNote stock

On Eulerpool you can find the complete historical development of Net Financing Cash Flow BioNote since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's BioNote historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — BioNote

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — BioNote